Dudediligence.

Hyperion DeFi, Inc

HYPDNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$1,625Sep ’24$28,093Dec ’24$14,720Mar ’25$302,506Sep ’25$496,229Dec ’25$244,271Mar ’26$357,693Jun ’26
Net income, by quarter
−$7.9MSep ’24−$20.0MDec ’24−$3.5MMar ’25−$8.7MJun ’25$6.6MSep ’25−$39.8MDec ’25$8.8MMar ’26$31.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$14.0Mnone on file$3,787$57,336$813,455
Gross profit$12.4Mnone on file−$12,218−$3.9M$510,165
Operating income−$13.0M−$26.9M−$25.4M−$48.7M−$46.7M
Net income−$12.8M−$28.0M−$27.3M−$49.8M−$45.3M
Operating cash flow−$20.9M−$25.1M−$23.8M−$30.1M−$14.8M
Free cash flow−$22.1M−$25.6M−$26.7M−$30.3Mnone on file
Cash$19.5M$22.9M$14.8M$2.1M$6.3M
Shares outstanding28.4M36.7M569.4K1.5M8.7M